Translate this page into:
Clinical performance and durability of short taper-wedge femoral stems in direct anterior total hip arthroplasty: Insights from a five-year retrospective analysis
⁎Corresponding author: Shuvalaxmi D. Haselton. shuvalaxmidasgupta@texashealth.org
-
Received: ,
Accepted: ,
This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Abstract
Short-taper-wedge stems have gained increasing adoption in direct anterior total hip arthroplasty owing to their bone-preserving geometry and favorable suitability for implantation through limited exposures. The objective of this study was to assess 5-year clinical and radiographic outcomes, implant survivorship, and risk factors for failure. We hypothesized that mid-term survivorship of short-taper-wedge stems would be equivalent to or exceed that of traditional designs, with a lower complication rate in Dorr-A and B femora.
A retrospective analysis was conducted on a consecutive cohort of 128 primary-DA-THAs performed with the Taperloc Microplasty stem. Clinical outcomes were measured using the Harris Hip Score (HHS), while radiographic evaluations assessed implant positioning, subsidence, and complications. Follow-up was completed at 2-weeks, 6-weeks, 6-months, 1-year, 2-years, and 5-years.
Revision-free implant survivorship was 92.7% at five-years. The HHS improved significantly from a mean of 47.5 preoperatively to 96.8 at five-years (p < 0.0005). The overall complication rate was 7.03%, comprised of early implant subsidence and periprosthetic fractures in older patients (mean 77.8 years) with diminished bone stock. Multivariate analysis identified increasing age as the sole predictor of complications (p = 0.008), all of which were successfully managed with revision to modular, diaphyseal-engaging-femoral stems.
Short-taper-wedge-femoral stems are a reliable option for primary-DA-THA, with revision-free survivorship of 92.7% at 5-years-postoperatively. Early periprosthetic fractures, the predominant complication in this series, occurred in older patients with brittle bone, supporting use of cemented fixation in this high-risk population. Long-term monitoring is underway to further inform durability and outcomes with use of this stem in primary DA-THA settings.
Keywords
Taper-wedge femoral stem
Clinical performance
Survivorship
Direct-anterior total hip arthroplasty
1 Introduction
Short tapered-wedge femoral stems have gained significant traction in primary total hip arthroplasty (THA) over the past decade, driven by their unique biomechanical advantages and utility in specific clinical contexts 1–8.
Short tapered-wedge femoral stems have seen increasing adoption in primary total hip arthroplasty due to their favorable biomechanical profile and versatility across surgical approaches. The Taperloc Microplasty stem (Zimmer Biomet, Warsaw, IN) represents a shortened modification of the standard Taperloc design, reduced in length by 35 mm to facilitate minimally invasive techniques while maintaining the wedge-shaped titanium geometry and proximal porous plasma spray coating to achieve reliable metaphyseal fixation. These design features enable use through smaller incisions, including the direct anterior (DA) approach, and may be particularly advantageous in patients with Dorr A femoral morphology or pronounced metaphyseal–diaphyseal mismatch. In such cases, conventional longer stems may require more extensive canal preparation, prophylactic cerclage cabling, or even corrective osteotomy to achieve stability. Shorter stems also preserve distal bone stock, potentially simplifying future revision surgery—an important consideration in younger, active patients at higher risk of revision during their lifetime.7,9
While short, taper-wedge femoral stems offer significant promise, their widespread adoption has been constrained by a lack of large-scale clinical studies with extended follow-up, particularly in the context of the DA approach. Concerns remain regarding fixation durability, especially in patients with capacious femoral canals or thin cortical bone, where the absence of diaphyseal engagement inherent to these designs may increase the risk of implant subsidence or periprosthetic fractures. Moreover, the DA approach, though increasingly popular, is characterized by a steep initial learning curve due to technical challenges in achieving adequate femoral exposure and canal preparation, with cortical perforations frequently observed during early adoption.9,10 As the DA approach continues to gain traction, rigorous investigations are needed to validate the feasibility, safety, and long-term performance of short femoral stems within this specific surgical context.
The objective of this retrospective study was to evaluate clinical and radiographic outcomes at a minimum of 5-years postoperatively in a consecutive series of 128 patients undergoing primary THA with a short tapered-wedge femoral stem at a single, high-volume dedicated total joint replacement center. We hypothesized that the mid-term survivorship of short taper-wedge stems would be equivalent to or greater than that of traditional designs, with lower complication rates in Dorr A and B femora.
2 Methods
2.1 Study design and sample population
A consecutive cohort of patients undergoing primary press-fit DA-THA between January 2012 and December 2016 were retrospectively analyzed using our institution's total joint registry database. The surgeries were performed by two fellowship-trained arthroplasty surgeons: one with over 5 years of independent practice and the other with more than 40 years of experience using the short taper-wedge stem in the DA approach, both well beyond the learning curve associated with this technique.11 Patients presenting with end-stage osteoarthritis (OA), avascular necrosis (AVN), and inflammatory (IA) or rheumatoid arthritis (RA), who were eligible for a cementless stem based on preoperative radiographic assessment of adequate metaphyseal bone stock, were considered eligible for inclusion in this study. The Taperloc Microplasty stem was selected to accommodate complex femoral morphologies (such as Dorr A femurs or metaphyseal-diaphyseal mismatch) or to facilitate the DA approach. The stem was preferred for Dorr A and B femurs due to its metaphyseal fixation design but also used in select Dorr C cases with adequate metaphyseal bone stock. Patients undergoing non-elective, revision arthroplasty, or surgeries for tumor- or infection-related etiologies were excluded from this study.
Baseline demographic characteristics were abstracted for all patients, including age, gender, body mass index (BMI, kg/m2), American Society of Anesthesiologist (ASA) physical classification score, primary diagnosis and medical comorbidities (diabetes, rheumatoid arthritis, concomitant degenerative joint disease of the spine, and anxiety/depression).
2.2 Surgical technique
All primary total hip arthroplasties (THAs) were performed using the DA approach on a Hana traction table (Mizuho OSI, Union City, CA). Preoperative planning was conducted using TraumaCad software (Brainlab, Munich, Germany), and intraoperative fluoroscopy, combined with Radlink GPS digital radiography alignment software (Radlink™ Inc., El Segundo, CA), ensured precise component alignment. Target acetabular component orientation was 15–20 degrees of anteversion and 40–45 degrees of inclination, with a combined version of the femoral and acetabular components aiming for 35°. Restoration of leg length and offset was also confirmed intraoperatively.
The DA approach was performed through a longitudinal skin incision with an L-shaped capsulotomy, which was meticulously repaired during wound closure. Implantation of a short, taper-wedge titanium alloy femoral stem (Taperloc Microplasty, Zimmer Biomet, Warsaw, IN; Fig. 1), featuring a proximally porous plasma spray coating, was achieved using a "broach-only" technique. Careful attention was directed toward achieving appropriate lateralization to facilitate a slightly valgus-biased stem position. A 36-mm ceramic femoral head was paired with a vitamin E-infused, highly crosslinked polyethylene liner unless spinopelvic rigidity was identified on preoperative lumbar radiographs, in which case a G7 dual mobility construct (Zimmer Biomet, Warsaw, IN) was selected to mitigate the risk of dislocation (see Fig. 2).

Postoperatively, patients were made weight-bearing as tolerated (WBAT) with protected-gait for the first two weeks. Transition to unassisted ambulation was guided by the absence of a limp or thigh pain during alternating gait. Postoperative follow-up evaluations were scheduled at 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years, and 5 years per institutional protocol.
2.3 Radiographic assessment
Standing anteroposterior (AP) pelvis and false profile lateral femur radiographs were obtained preoperatively, and postoperatively at 6-weeks, 1-year, 3-year and 5-year intervals.
Radiographic evaluations were performed by two fellowship trained orthopedic surgeons, blinded to clinical outcomes, using digital calipers in TraumaCad software (Brainlab, Munich, Germany). Intraoperative imaging was done using the C-arm and as a rule the size of the final implant used was one size larger than the broach. A straight ruler was used to determine consistent intra medullary positioning and to equalize leg length. Key criteria for identifying complications included subsidence (>2 mm vertical migration from the initial postoperative radiograph, measured from the stem shoulder to the lesser trochanter); osseointegration per Engh criteria (including absence of reactive lines and presence of spot welds), radiolucent lines assessed in Gruen zones 1–7, with progressive lines >2 mm considered significant, and stem alignment (varus/valgus deviation >3° from neutral femoral axis).
2.4 Outcome measures
Clinical outcomes were assessed using the Harris Hip Score (HHS), a validated and widely utilized instrument for evaluating hip pain and function.12 The HHS encompasses domains such as pain, daily activities, and range of motion, offering a comprehensive measure of patient outcomes and satisfaction. Clinically meaningful improvement is defined as a 20-point increase in the score.13 Additional metrics analyzed included mean estimated blood loss (EBL), length of hospital stay (LOS), and the distance ambulated within 24 h postoperatively. All perioperative complications were recorded, including prosthetic joint infection (PJI), dislocation, venous thromboembolism, periprosthetic fracture, and any revision surgeries. Five-year stem survivorship was defined by the absence of patient-reported thigh pain, absence of varus malalignment, no radiographic evidence of subsidence, and no revision surgery for any reason.
2.5 Statistical analysis
A priori power analysis assuming a small effect size (0.10), alpha level of 0.05, power of 0.80, and inclusion of up to 8 explanatory variables with a presumed 10% attrition rate rendered a minimum requisite sample size calculation of 35 patients.
Descriptive statistics were reported as means and standard deviations for quantitative variables and as counts and frequencies for categorical variables. All variables were evaluated for distribution of normality using a combination of histograms, Q-Q plots, and Shapiro-Wilk tests (normality indicated by p > 0.05). Mean differences in Harris Hip Score (HHS) were evaluated using a one-way, repeated measures ANOVA with post-hoc comparisons performed using paired t-tests with Bonferroni adjustment for multiple comparisons. A stepwise multiple linear regression procedure was performed to determine whether any significant (p < 0.05) or near-significant (p < 0.10) factors from univariate analyses served as independent predictors of postoperative complications. Statistical significance for all comparisons was set at P < 0.05 (two-tailed). All analyses were conducted using IBM SPSS Statistics Version 29.0 (Statistical Package for the Social Sciences, Chicago, IL, USA) and SAS Statistical Software Version 9.4 (SAS Institute Inc., Cary, NC, USA).
3 Results
3.1 Participants and descriptive data
The final patient cohort comprised of 128 patients (74 females, 54 males) with a mean age of 63.7 years (SD, 8.9 years and mean BMI of 29.8 kg/m2 (SD, 5.4 kg/m2). The vast majority of patients undergoing THA demonstrated end-stage osteoarthritis (n = 117; 91.4%), with other etiologies such as inflammatory arthritides or avascular necrosis comprising a minor subset. Based on preoperative radiographs, femoral morphology was classified as Dorr A in 20 patients (15.62%), Dorr B in 95 patients (74.22%) and Dorr C in 13 patients (10.16%). Intraoperatively, there were no indications of complications. The mean hospital LOS was 2.13 days (SD, 0.76). Postoperatively during their hospital stay, patients ambulated a mean distance of 211.9 feet (SD, 91.0). Additional demographics are summarized in Table 1 (Appendix A).
3.2 Patient reported outcomes
HHS demonstrated a mean improvement of mean difference of 49.3 points between preoperative and immediate postoperative time points (95% CI [44.57, 54.06], p < 0.005). This magnitude of this improvement relative to preoperative (baseline) HHS scores was sustained at five-years postoperatively (mean HHS score, 96.8; F (1.69, 191.83) = 626.64, p < 0.0005).
3.3 Complications
A total of nine (7.03%) patients required revision: five (3.91%) for periprosthetic fracture, two (1.56%) for dislocation (mean 328.5 days, range 219–438 days), and two (1.56%) for femoral stem subsidence without fracture (mean 1252.5 days, range 23–2482 days). Of those with periprosthetic fracture, 4 (80%) occurred within 40 days postoperatively (mean 14.8 days, range 2–39 days, Fig. 1). All cases were Vancouver B2 periprosthetic fractures (component subsidence with adequate bone stock) and required revision to a modular, diaphyseal-engaging revision femoral stem. Two of the five fractures occurred in Dorr B femurs, and three occurred in Dorr A femur; no fractures were observed in Dorr C femur. Intraoperatively, there were no indications of complications. All complications occurred in patients with osteoarthritis, with the exception of a single periprosthetic fracture in a patient with avascular necrosis. Multivariate regression analysis identified increased age to be the only statistically significant predictor of postoperative complication (β = 0.008; 95% CI, 0.002 to 0.013, p = 0.008; Table 2).
4 Discussion
The adoption of short, metaphyseal-engaging tapered-wedge stems in primary, cementless THA has increased substantially over the past decade, largely due to their versatility and efficacy in addressing complex femoral anatomies.14 While concerns have been raised regarding the mid- and long-term rotational and axial stability of these stems due to their absence of diaphyseal engagement, our study demonstrated a revision-free survivorship rate of 92.9% at 5 years in a consecutive cohort of 128 consecutive patients undergoing primary THA with the Taperloc Microplasty short femoral stem via the DA approach (Fig. 2). To our knowledge, this represents the first evaluation of midterm clinical and radiographic outcomes for short femoral stems in the context of the DA approach, a technique recognized for its initially steep learning curve due to challenges in femoral exposure and canal preparation, with cortical perforations frequently reported during early adoption.9,10

A particular advantage of short femoral stems is that they are well-suited to address potentially challenging femoral morphologies such as Dorr A femurs, metaphyseal-diaphyseal mismatch, iliotrochanteric overhang, and significant abdominal pannus. These anatomies often complicate femoral exposure and stem placement via the DA approach. While comparative analysis of our results is challenging due to limited studies on short taper-wedge stems in this context, existing literature supports their utility. Saragaglia et al. reported 100% five-year survivorship of the Taperloc Microplasty stem in a series of 108 patients (mean age 58.8 years, SD 10 years) undergoing THA via a piriformis-sparing posterior approach. Nearly 50% of their cohort presented with Dorr A femurs, and no periprosthetic fractures or subsidence occurred, though 7.5% exhibited distal pedestal formation.6 Similarly, Lombardi et al. compared 389 primary THAs using conventional-length femoral stems and 269 THAs with the Taperloc Microplasty stem via a modified Hardinge approach, reporting a periprosthetic fracture rate of 3.1% for conventional stems versus 0.4% for shorter stems, with no significant differences in survivorship or PROMs at five years.14 Luger et al. also found a 1.5% reduction in periprosthetic fractures with short stems (Fitmore) compared to straight stems (Alloclassic SL/SLO; Zimmer Biomet) at one year postoperatively (p = 0.02) in a cohort of 1147 cementless primary THAs matched via propensity scores.15
In contrast, nine patients in our series (7.03%) required revision, including five cases of Vancouver B2 periprosthetic fractures occurring early (mean 14.8 days postoperatively). Age emerged as the sole significant predictor of complications, with patients experiencing fractures having a mean age of 77.8 years. Consistent with guidelines developed since the inception of this study, hybrid THA is now employed in our practice, with a cemented femoral stem and a cementless or press-fit acetabular component used in male patients over 75 years, female patients over 70 years, and in those with osteoporosis or a capacious (Dorr C) femoral canal 16–22. Supporting these findings, Sershon et al. analyzed 2417 patients undergoing THA with a short, single-wedge taper stem and 3892 with a fit-and-fill stem, observing a 2.3-fold increased risk of periprosthetic fractures with the former, particularly in patients aged >65 years.23 Bishop et al. also evaluated peak stress distribution in the proximal femur using four matched-pair cadaveric femora implanted with small taper-wedge and standard-length femoral stems. They reported stress increases of up to 35% when stems were placed in varus, a risk significantly mitigated by valgus stem positioning.24 Hayama et al. further validated these findings in a cohort of 257 Asian patients with DDH undergoing THA via a posterior approach, reporting no cases of implant subsidence, periprosthetic fractures, or failure of bony ingrowth at a mean follow-up of four years.25 Their findings emphasize the critical importance of avoiding varus positioning and achieving slight valgus alignment, as well as the adaptability of short stems for accommodating variations in femoral version. Our experience similarly underscores the necessity of achieving proper lateralization and valgus positioning to mitigate the risks of varus malposition or calcar compromise, an adjustment facilitated by the smaller profile of short stems.
The Taperloc Microplasty stem offers several advantages, including a shortened design that preserves distal bone stock, reduces stress shielding through proximal load transfer, and facilitates insertion through the DA approach. Its metaphyseal fixation provides stable engagement in narrow, funnel-shaped Dorr A femora. In this cohort, three fractures occurred in Dorr A femurs and two in Dorr B femurs, all within six weeks of surgery. All femoral stems in the study achieved bone-ingrowth. They were tightly fitted within the canal using fluoroscopic guidance, maximizing fit and fill of the stem in the canal. The surgical technique employed by the experienced surgeons was rarely associated with issues such as early subsidence or rotational instability (only two in this series). Given that minimal postoperative pain is often associated with the direct anterior approach,26 patients often came off a protective gait too early. Therefore, careful adherence to standardized postoperative protocols remains critical, emphasizing good gait patterns and safety to optimize outcomes, particularly in the first six weeks. This highlights the importance of robust patient counseling to support recovery, especially for Dorr A patients, when using this stem.
Limitations of the stem include potential instability in patients with poor bone quality or capacious canals, reflected by subsidence and periprosthetic fractures in older individuals—consistent with reliance on metaphyseal fixation without diaphyseal support. In our series, two cases of subsidence (≤3 mm) were observed; both were clinically asymptomatic, showed no progressive radiolucent lines, and demonstrated complete osseointegration at latest follow-up. Subsidence of this degree is generally considered clinically acceptable. Gallart et al., in a series of 32 THAs using the Taperloc Complete Microplasty stem with mean 36.5-month follow-up, reported one case of 1 mm subsidence, which did not progress or result in radiolucent lines.27 Similarly, a mid-term series of 119 stems reported no subsidence greater than 3 mm and radiolucent lines in only 2% of cases,6 affirming reliable osseointegration while acknowledging the potential for early subsidence in high-risk groups. Collectively, these findings support the clinical utility of the Microplasty stem in appropriately selected patients, while reinforcing the continued role of cemented fixation in elderly or osteoporotic individuals.
Strengths of this study include an adequate sample size, robust five-year clinical and radiographic follow-up, and the exclusive focus on assessing the feasibility and clinical outcomes of short femoral stem placement via the DA approach. However, a few important limitations warrant consideration. The retrospective design of the study inherently introduces selection bias, although this was largely mitigated through the use of a consecutive cohort and standardized protocols. Secondly, clinical outcomes were assessed using the Harris Hip Score (HHS), which provides valuable insight into pain, function, and range of motion but lacks the breadth of additional PROMs such as WOMAC or HOOS Jr., which were excluded due to incomplete data at five years for a substantial portion of the cohort (data availability <70%). Future analyses from our ongoing long-term follow-up will incorporate these metrics to provide a more comprehensive assessment of patient-centered outcomes. Finally, this study evaluated a single short, tapered-wedge stem design (Taperloc Microplasty, Zimmer Biomet, Warsaw, IN) and may not be directly applicable to other vendor designs of short femoral stems, which can exhibit considerable variability in geometry and porous coatings. Long-term follow-up at 10- and 15-years is ongoing and is anticipated to offer further insights into implant survivorship and clinical outcomes.
5 Conclusions
Short taper-wedge femoral stems have demonstrated reliability in primary DA-THA, with a revision-free survivorship of 92.7% at five-years postoperatively. These stems are particularly well-suited for addressing complex femoral anatomies, including Dorr-A femurs, metaphyseal-diaphyseal mismatch, and challenging scenarios such as wide iliotrochanteric overhang or abdominal pannus, where conventional femoral stems may present technical difficulties. The majority of complications in this series were early periprosthetic fractures, predominantly occurring in patients with a mean age of 77.8 years and poor bone quality. These findings have supported our adoption of cemented femoral fixation in such patients, aligning with national trends that have emerged since the inception of this study. Long-term data collection is ongoing to provide additional insights into the durability and versatility of short taper-wedge stems in primary DA-THA.
Ethical statement
Ethical approval for this study was obtained from the Texas Health Resources and UT Southwestern Medical Center Institutional Review Boards on August 6th, 2020; with the following determinations:
Waiver of Documentation of Consent § 46.117(c);
Waiver of Documentation of Consent Qualifications § 46.117(c).
Informed patient consent
The study was approved by the Texas Health Resources Institutional Review Board and the UT Southwestern Medical Center Institutional Review Board, under the revised Common Rule (45 CFR 46). The IRB approved a waiver of documentation of informed consent permitting verbal consent to be obtained. All participants provided verbal informed consent after being a read a detailed information script describing the study's purpose, procedures, risks, benefits, voluntariness and confidentiality protections. Verbal consent was documented in the study records by research coordinators.
Credit author statement
Shuvalaxmi D. Haselton: Patient follow-up, data collection, data analysis, writing – original draft.
Vivek P. Chadayammuri: Formal data analysis, writing – review and editing.
Roger H. Emerson: Conceptualization, patient contribution, investigation, writing – review and editing, supervision.
Funding statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
References
- Tapered wedge stems decrease early postoperative subsidence following cementless total hip arthroplasty in Dorr type C femurs compared to fit-and-fill stems. J Orthop Surg Res. 2022;17(1):223.
- [Google Scholar]
- Outcome of the cementless Taperloc stem: a comprehensive literature review including arthroplasty register data. Acta Orthop. 2011;82(2):143-148.
- [Google Scholar]
- Uncemented total hip arthroplasty with a tapered femoral component: a 22 to 26-year follow-up study. Orthopedics. 2010;33(9):639.
- [Google Scholar]
- Uncemented total hip arthroplasty using a tapered femoral component in obese patients: a 18-27 year follow-up study. J Arthroplast. 2014;29(7):1365-1368.
- [Google Scholar]
- Total hip arthroplasty with an uncemented tapered femoral component in patients younger than 50 years of age: a minimum 20-Year Follow-Up study. J Arthroplast. 2016;31(6):1275-1278.
- [Google Scholar]
- Mid-term results of 119 taperloc microplasty™ femoral stems after a mean 61 months (50-82) of follow-up. . 2020;106(8):1501-1506.
- [Google Scholar]
- Is the length of the femoral component important in primary total hip replacement? Bone Jt J. 2014;B(4):442-448.
- [Google Scholar]
- Short stems versus conventional stems in cementless total hip arthroplasty: a long-term registry study. J Arthroplast. 2018;33(6):1794-1799.
- [Google Scholar]
- Risk factors for perioperative femoral fractures: cementless femoral implants and the direct anterior approach using a fracture table. J Arthroplast. 2016;31(9):2013-2018.
- [Google Scholar]
- Adopting the direct anterior approach: experience and learning curve in a Chinese patient population. J Orthop Surg Res. 2019;14(1):218.
- [Google Scholar]
- What is the learning curve for the anterior approach for total hip arthroplasty? Clin Orthop Relat Res. 2015;473(12):4565-4566.
- [Google Scholar]
- Is the Harris hip score system useful to study the outcome of total hip replacement? Clin Orthop Relat Res. 2001;384:189-197.
- [Google Scholar]
- Clinically important improvement thresholds for Harris hip score and its ability to predict revision risk after primary total hip arthroplasty. BMC Muscoskelet Disord. 2016;17(1):256.
- [Google Scholar]
- A short tapered stem reduces intraoperative complications in primary total hip arthroplasty. Clin Orthop Relat Res. 2012;470(2):450-461.
- [Google Scholar]
- Periprosthetic femoral fractures in cementless short versus straight stem total hip arthroplasty: a propensity score matched analysis. J Arthroplast. 2023;38(4):751-756.
- [Google Scholar]
- Periprosthetic fractures: a rising tide of hip arthroplasty failure noted in the American joint replacement registry and the preventative role of cemented stems. J Arthroplast. 2024;39(9S2):S454-S458.
- [Google Scholar]
- Cementation in total hip arthroplasty: history, principles, and technique. EFFORT Open Rev. 2022;7(11):747-757.
- [Google Scholar]
- Cemented femoral component use in hip arthroplasty. J Am Acad Orthop Surg. 2019;27(4):119-127.
- [Google Scholar]
- Perioperative periprosthetic femur fractures are strongly correlated with fixation method: an analysis from the American joint replacement registry. J Arthroplast. 2019;34(7S):S352-S354.
- [Google Scholar]
- Cemented femoral stem fixation: back to the future. J Arthroplast. 2023;38(7 Suppl 2):S38-S44.
- [Google Scholar]
- Is cemented or cementless femoral stem fixation more durable in patients older than 75 years of age? A comparison of the best-performing stems. Clin Orthop Relat Res. 2018;476(7):1428-1437.
- [Google Scholar]
- A review of current fixation use and registry outcomes in total hip arthroplasty: the uncemented paradox. Clin Orthop Relat Res. 2013;471(7):2052-2059.
- [Google Scholar]
- Periprosthetic femur fracture risk: influenced by stem choice, not surgical approach. J Arthroplast. 2021;36(7S):S363-S366.
- [Google Scholar]
- Biomechanics of short hip endoprostheses—the risk of bone failure increases with decreasing implant size. Clin Biomech. 2010;25(7):666-674.
- [Google Scholar]
- Clinical results of a short stem with flat tapered wedge design in primary total arthroplasty for hip dysplasia in Asians. J Orthop Surg. 2020;28(3)
- [Google Scholar]
- Reduced postoperative pain in total hip arthroplasty after minimal-invasive anterior approach. Int Orthop. 2011;36(3):491-498.
- [Google Scholar]
- Early clinical and radiological outcomes for the Taperloc complete microplasty stem. Eur J Orthop Surg Tarumatol. 2019;29(3):619-624.
- [Google Scholar]
